R. B.M. Aggio
Irritable bowel syndrome and active inflammatory bowel disease diagnosed by faecal gas analysis
Aggio, R. B.M.; White, P.; Jayasena, H.; de Lacy Costello, B.; Ratcliffe, N. M.; Probert, C. S.J.
Authors
Paul White Paul.White@uwe.ac.uk
Professor in Applied Statistics
H. Jayasena
Benjamin De Lacy Costello Ben.DeLacyCostello@uwe.ac.uk
Associate Professor in Diagnostics and Bio-Sensing Technology
Norman Ratcliffe Norman.Ratcliffe@uwe.ac.uk
Professor in Materials & Sensors Science
C. S.J. Probert
Abstract
© 2016 John Wiley & Sons Ltd Background: Inflammatory bowel disease and irritable bowel syndrome may present in a similar manner. Measuring faecal calprotectin concentration is often recommended to rule out inflammatory bowel disease, however, there are no tests to positively diagnose irritable bowel syndrome and invasive tests are still used to rule out other pathologies. Aim: To investigate a platform technology for diagnosing inflammatory bowel disease and irritable bowel syndrome based on faecal gas.
Methods: The platform technology is composed of a gas chromatography column coupled to a metal oxide gas sensor (OdoReader) and a computer algorithm. The OdoReader separates the volatile compounds from faecal gas and the computer algorithm identifies resistance patterns associated with specific medical conditions and builds classification models. This platform was applied to faecal samples from 152 patients: 33 patients with active inflammatory bowel disease; 50 patients with inactive inflammatory bowel disease; 28 patients with irritable bowel syndrome and 41 healthy donors (Control).
Results: The platform classified samples with accuracies from 75% to 100% using rigorous validation schemes: namely leave-one-out cross-validation, 10-fold cross-validation, double cross-validation and their Monte Carlo variations. The most clinically important findings, after double cross-validation, were the accuracy of active Crohn's disease vs. irritable bowel syndrome (87%; CI 84–89%) and irritable bowel syndrome vs. controls (78%; CI 76–80%). These schemes provide an estimate of out-of-sample predictive accuracy for similar populations.
Conclusions: This is the first description of an investigation for the positive diagnosis of irritable bowel syndrome, and for diagnosing inflammatory bowel disease.
Journal Article Type | Article |
---|---|
Acceptance Date | Sep 14, 2016 |
Online Publication Date | Nov 10, 2016 |
Publication Date | Jan 1, 2017 |
Deposit Date | Nov 14, 2016 |
Publicly Available Date | Nov 10, 2017 |
Journal | Alimentary Pharmacology and Therapeutics |
Print ISSN | 0269-2813 |
Electronic ISSN | 1365-2036 |
Publisher | Wiley |
Peer Reviewed | Peer Reviewed |
Volume | 45 |
Issue | 1 |
Pages | 82-90 |
DOI | https://doi.org/10.1111/apt.13822 |
Keywords | irritable, bowel, syndrome, active, inflammatory, bowel, disease, faecal, gas, analysis |
Public URL | https://uwe-repository.worktribe.com/output/900591 |
Publisher URL | http://dx.doi.org/10.1111/apt.13822 |
Contract Date | Dec 9, 2016 |
Files
Supplementary_data_R4.docx
(1.7 Mb)
Document
FigureS3New.pdf
(548 Kb)
PDF
FigureS1.pdf
(1.3 Mb)
PDF
Figure2New.pdf
(206 Kb)
PDF
Figure1New.pdf
(308 Kb)
PDF
AggioEtAl_R4.docx
(63 Kb)
Document
AggioEtAl_R4.pdf
(1 Mb)
PDF
You might also like
Cyclic ortho ester fuel additive
(2014)
Patent
A review of the volatiles from the healthy human body
(2014)
Journal Article
Urinary volatile organic compounds for the detection of prostate cancer
(2015)
Journal Article
Downloadable Citations
About UWE Bristol Research Repository
Administrator e-mail: repository@uwe.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search